Trials / Completed
CompletedNCT03115021
Neurophysiological Effects of tPCS and tDCS on Patients With Disorders of Consciousness
- Status
- Completed
- Phase
- Phase 1
- Study type
- Interventional
- Enrollment
- 12 (actual)
- Sponsor
- University of Liege · Academic / Other
- Sex
- All
- Age
- 18 Years – 75 Years
- Healthy volunteers
- Not accepted
Summary
This study aims at comparing the effects of transcranial direct current stimulation and transcranial pulsed current stimulation on neurophysiological outcomes on patients with disorders of consciousness. This study also aims to evaluate the effects of these techniques on patients' level of consciousness.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DEVICE | Active tPCS | A current intensity of 2na and a stimulation frequency range of 6-10 Hz will be used with a peri-auricular ear-clip electrode montage for 20 minutes. |
| DEVICE | Active tDCS | A current intensity of 2mA will be used for 20minutes. The electrodes that will be used will be standard sponge electrodes. The anode will be place over the left prefrontal cortex and the cathode over the right supraorbitofrontal area. |
| DEVICE | Sham tPCS | Sham tPCS will consist of applying the same parameters as for active but the corresponding device will be turned off after 30 seconds as to simulate the initial sensation of the active current. A current of 2mA will still be used (but turned off after 30 sec). The electrodes that will be used will be the same as for the active tPCS condition and the electrodes placement as well. |
| DEVICE | Sham tDCS | Sham tDCS will consist of applying the same parameters as for active but the corresponding device will be turned off after 30 seconds as to simulate the initial sensation of the active current. A current of 2mA will still be used (but turned off after 30 sec). The electrodes that will be used will be the same as for the active tDCS condition and the electrodes placement as well. |
Timeline
- Start date
- 2018-05-01
- Primary completion
- 2019-09-30
- Completion
- 2019-10-30
- First posted
- 2017-04-14
- Last updated
- 2021-10-28
Locations
1 site across 1 country: Belgium
Source: ClinicalTrials.gov record NCT03115021. Inclusion in this directory is not an endorsement.